SGI-DNA Inc. today announced the launch of the BioXp™ 3200 System Early Access Program giving researchers priority access to this one of a kind, personal DNA work station which delivers high quality synthetic DNA fragments. The BioXp™ Instrument has the capacity to simultaneously build 32 unique double-stranded DNA fragments. It is the first instrument system of its kind and empowers researchers with the ability to produce high quality synthetic DNA fragments virtually hands free.
Daniel Gibson, Ph.D., VP DNA Technology at Synthetic Genomics, Inc. states, "The vision is to evolve this system with greater capabilities by continuing to develop downstream applications for synthetic biology. Over time, the BioXp™ System will allow researchers to focus on experimental design instead of performing many of the tedious tasks of cloning and expression."
In addition to the opportunity to significantly advance their synthetic biology research, Early Access Program customers will enjoy exclusive perks such as an enhanced level of technical and customer support, including priority treatment of obtaining their constructs whether provided via BioXp™ DNA Assembly reagents or through SGI-DNA's custom synthesis service that excels in synthesizing long and difficult constructs.
The BioXp™ system utilizes the Gibson Assembly® technology and is coupled with a unique error correction formulation resulting in the synthesis of highly accurate DNA fragments. DNA fragments are ready for many applications including off-line sequencing, cloning, assembly into larger fragments, and expression into RNA and proteins. SGI-DNA's custom gene synthesis service option provides synthesis of longer and more challenging constructs for all gene synthesis needs for customers.
The Gibson Assembly® method was developed in 2009 by Daniel Gibson, Ph.D., and his colleagues at the J. Craig Venter Institute during the team's quest to construct the first synthetic cell. Since its introduction to the life science community, the Gibson Assembly® method has become a mainstay in many synthetic biology laboratories and has attracted interest from both the academic and commercial life sciences community due to its ease-of-use, robustness, and flexibility.